Anti-social Behaviour, Crime and Policing Bill Debate
Full Debate: Read Full DebateBaroness Meacher
Main Page: Baroness Meacher (Crossbench - Life peer)Department Debates - View all Baroness Meacher's debates with the Home Office
(11 years ago)
Lords ChamberMy Lords, in speaking to Amendment 56NA, I commend the noble Baroness, Lady Smith, and the noble Lord, Lord Rosser, for tabling it. We need government and, indeed, all political parties to get together to try to create a safer world for our young people while new psychoactive substances are so readily available to them. The amendment has merit on two grounds: first, it seeks to remove these substances from the shop window, as one might put it, which has to be helpful; and secondly, a feature of the amendment is that it focuses exclusively on suppliers and does not seek to criminalise the users of these substances. Those are two important points in favour of the amendment.
However, we need to be aware of some of the potential problems with the amendment. My only qualification for speaking today is that I chaired the APPG inquiry into new psychoactive substances, which received evidence from all the major governmental and non-governmental organisations involved in this field, as well as academics and those working on the front line, who really understand the implications of policies and perhaps their ineffectuality. As a result of that work, I have a number of concerns.
The first is the absence of proportionality or logic in the proposal. We have to accept, albeit reluctantly, that a sizeable proportion of young people will use drugs that may harm them. Our aim must surely be to reduce the incidence of addiction to any dangerous drug and, in particular, to reduce addiction to the most dangerous drugs, whether legal or illegal. We also need to reduce as far as possible the risk of a young person having a single dose of a substance that can cause death or serious injury.
Our drug policies must face reality. We will not stamp out drug use through bans and punishment. Our only hope is to create a rational system which makes abundantly clear to our young people those substances that are seriously dangerous, those that cause medium harm and those with short-term and relatively mild ill effects. We have not even begun to go down the road of proportionality in our drugs policy and, unfortunately, this amendment does not adopt this essential principle. Some other countries have done so, with impressive results, and even the US is beginning to take steps in a rational direction.
My comments on this amendment reflect my increasing conviction of the need for proportionality in our drug policies, combined with extensive information, education, treatment and psychological support for those who need it. Only with such an approach will we have a chance to achieve a safer drugs policy.
We need young people to respect the law. If the law is an ass, young people will get round it or simply ignore it. The amendment does not offer a proportionate response to these substances. There is also a lack of logic in the amendment, if I may put it that way; for example,
“a herbal substance with the appearance of cannabis”,
would be banned under this amendment. Why those particular herbal substances? They may in fact present a far lower risk and be far preferable for the health of young people than legal drugs such as tobacco and alcohol, and certainly the many other drugs that are available.
The Angelus Foundation, the organisation behind this amendment, argues in its briefing that the ban should apply only to synthetic psychoactive substances. It accepts that head shops have sold a number of substances that are non-addictive, do not cause significant social problems or are mild in their effects. It rightly says that such substances should not be caught by this amendment. But why should synthetic substances of similarly low risk and lack of social consequences be banned? Young people will very quickly realise the inconsistency in the situation.
Turning to a different issue, I find myself in agreement with the Home Office concern that the amendment completely bypasses the ACMD—the Advisory Council on the Misuse of Drugs. That august body of scientists should be at the heart of drug policy-making, assessing risks and actually making decisions—if I had my way —on the classes of different drugs. If we had scientists making these decisions, we would arrive at a more sensible set of policies.
Another and quite different concern is that if this amendment were passed it might be seen as a solution to the problem of NPS. Of course, a proportion of these young people will immediately go to the web if they cannot get what they want from the local head shop, and that proportion could be very close to 100%. Young people know all about the web—far more than I do—and it would not take them many minutes to realise that that is all they have to do to get what they want.
A very different question is whether the authors of the amendment explored the implications for research of this measure. Already, serious psychopharmacological researchers are having incredible difficulty obtaining the substances they need to undertake their research.
Also, have those supporting the amendment considered its cost implications? Trading standards representatives who gave evidence to our APPG on Drug Policy Reform made clear that if they are to take responsibility for policing head shops, they will need money to do it. That money has to cover the testing of those substances. It is no good their picking up a substance from a head shop if they have no idea what it is and no money to test it.
In conclusion, I applaud Angelus for its untiring work to try to reduce the access of young people to dangerous psychoactive substances. I welcome the attempt to reduce the risks to our young people of NPS. Whatever is agreed on the amendment, I hope that all political parties will work together to achieve improved policies to deal with the considerable risks presented to our young people by new psychoactive substances.
My Lords, I well understand the concern expressed by the noble Lord, Lord Rosser. For instance, I recognise what I can think of only as collusion between sellers and buyers of substances labelled bath salts, plant food, and so on. The noble Baroness says that this is her only qualification—come on, it is some qualification. We are very lucky to have her explain her point so clearly and, to my mind, so persuasively. As she says, trading standards authorities are as concerned as everybody else and struggling to find a way to deal with this. Has the noble Lord had comments on the proposal from the Trading Standards Institute?
Like the noble Baroness, the points that occurred to me, which I will not repeat but simply support, are: is this risk-based, is it evidence-based, will it bring the law into disrepute, does it recognise the psychology of the consumer? Chemists in China will stay ahead of the game and will use the internet. Of course we have to be smart, but we have to be smart differently, not try to beat them in the way that they are working.
I note the noble Lord’s point. I assure him that communication across government on this is very vigorous. I am sure he will agree that schools are not the only place where you can communicate with young people. We live in an age where there may be other less formal ways of conveying this message. I think the Government are right to see issues such as this also in those terms. I hope he will understand that our strategy is multifaceted; it is not just the single point that he made. The legal high trade is very resilient. It is inventive. There is no silver bullet for dealing with it. We need to ensure that whatever we are doing is equally resilient and effective.
The noble Lord, Lord Howarth may have been referring to a meeting of the Home Affairs Select Committee last week, at which my colleague Norman Baker, who is the Minister now responsible for drug policy, advised the committee that he is particularly keen that we look at all the options for tackling new psychoactive substances and learn from other countries in that regard—the noble Lord referred to New Zealand, for example—and that is what we are doing. However, even though this area is a cause for concern, caution needs to be exercised before we take any further steps. The possible unintended consequences need to be fully understood. That is why I think that the speeches of my noble friends Lady Hamwee and Lord Paddick, along with the excellent speeches from the noble Baroness, Lady Meacher, and the noble Lord, Lord Howarth, demonstrate that they are right to be concerned that the amendment and this new clause are deficient.
With this in mind, the move away from an evidence-based approach to drug harm that Amendment 56NA could imply is not one that the Government can take lightly; I think noble Lords were right to point that out. We are committed—as indeed we should all be committed—to ensuring that our legislative response continues to restrict the supply of harmful new psychoactive substances, both in our communities and online, by providing UK law enforcement with robust and practical powers to tackle this trade.
The Minister said that the way forward is more enforcement. Is he aware of the view of the UK Border Agency, ACPO and others that the legal framework and the enforcement behind it is actually not fit for purpose to deal with the particular problem of “new psychoactive substances”, as they are called—although in fact they are often not new?
Enforcement is, of course, part of the issue. If we decide that we need to restrict the supply, we will need to have the methodologies of enforcement. However, I think that I have made it clear that having evidence and information is equally important to underpin any legislative background against which we are operating. There is much going on in this area and I make a commitment to keep noble Lords informed of developments. With that in mind, I hope that the noble Lord will be able to withdraw his amendment.